Sean Mackay

Sean Mackay

Chief Business OfficeratStandard Biotools· In proxies 2022–2025

Pay in FY2025-47% from the year before · Standard Biotools stock -26.9% the same year

Sean Mackay was paid $1.7M in FY2025 (Dec), down 47%. Standard Biotools stock fell 26.9% that year.

Pay$100 in the stock at the end of FY21 → $33
Pay is from the Summary Compensation Table of each Standard Biotools proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Standard BiotoolsPublic company · 4 yr
    • Chief Business Officer2022 – Present · 4 yrStock in role -84%
  2. Abbratech Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?